3,509 SPDR S&P Biotech ETF $XBI Shares Acquired by Kercheville Advisors LLC

Kercheville Advisors LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.2% during the 3rd quarter, HoldingsChannel reports. The fund owned 28,304 shares of the exchange traded fund’s stock after buying an additional 3,509 shares during the quarter. SPDR S&P Biotech ETF makes up approximately 1.2% of Kercheville Advisors LLC’s investment portfolio, making the stock its 25th biggest holding. Kercheville Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $4,463,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vertrix Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 5.0% in the 3rd quarter. Vertrix Wealth Management LLC now owns 1,503 shares of the exchange traded fund’s stock valued at $237,000 after acquiring an additional 71 shares in the last quarter. Compound Planning Inc. lifted its position in shares of SPDR S&P Biotech ETF by 0.7% in the 1st quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock worth $1,391,000 after acquiring an additional 75 shares during the period. PeakShares LLC lifted its position in shares of SPDR S&P Biotech ETF by 5.2% in the 1st quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock worth $215,000 after acquiring an additional 84 shares during the period. Robertson Stephens Wealth Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 0.5% during the 3rd quarter. Robertson Stephens Wealth Management LLC now owns 21,640 shares of the exchange traded fund’s stock worth $3,412,000 after purchasing an additional 99 shares in the last quarter. Finally, Centaurus Financial Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 11.4% during the 1st quarter. Centaurus Financial Inc. now owns 1,254 shares of the exchange traded fund’s stock worth $160,000 after purchasing an additional 128 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI traded up $3.54 during trading on Monday, hitting $147.86. 8,385,527 shares of the stock were exchanged, compared to its average volume of 9,182,575. The company has a market capitalization of $10.21 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 1-year low of $106.30 and a 1-year high of $169.89. The company’s fifty day simple moving average is $158.09 and its 200-day simple moving average is $147.07.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.